Search clinical trials for: Octreotide microspheres

Total 562 results

Qilu Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers

Healthy Volunteers

China
Qilu Hospital of Shandong University

Not yet recruiting

A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

China
Novartis

Completed

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Diabetic Retinopathy

United States
Novartis Pharmaceuticals

Terminated

Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Diabetic Retinopathy
Novartis Pharmaceuticals

Terminated

Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Diabetic Retinopathy
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Head and Neck Cancer | Metastatic Cancer | Pheochromocytoma | Islet Cell Tumor

United States
Mayo Clinic

Active, not recruiting

Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema (CASTLE)

Lymphedema Arm

United States
Novartis

Completed

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Diabetic Retinopathy

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Single-dose Study of Octreotide Injection in Healthy Adult Subjects

Acromegaly

China
UNC Lineberger Comprehensive Cancer Center

Completed

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

Kidney Cancer

United States
Thomas Jefferson University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

Hepatocellular Carcinoma

United States
Advanced Accelerator Applications

Completed

A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours (NETTER-1)

Carcinoid Tumor of the Small Bowel | Neuroendocrine Tumour

United States, United Kingdom, Italy, Belgium, France, Germany, Portugal, Spain
Sinotau Pharmaceutical Group

Recruiting

A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs

Neuroendocrine Tumors

China
UNC Lineberger Comprehensive Cancer Center
Lantheus Medical Imaging

Completed

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau (CEUS-VHL)

Kidney Disease, Chronic | Von-Hippel Lindau

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization

Hepatocellular Carcinoma

United States
St. Josef Hospital Bochum

Completed

Effects of Intraarterial Octreotide on Pancreatic Texture

Pancreatic Fistula

Germany
University of British Columbia

Completed

Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Canada
University of California, Los Angeles
Varian Medical Systems

Recruiting

Genicular Artery Embolization Vs Observation for Symptomatic Knee Osteoarthritis (GRAVITY)

Knee Osteoarthritis | Degenerative Joint Disease of Knee

United States
University of Southern California
National Cancer Institute (NCI)

Recruiting

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

Breast Carcinoma

United States
Novartis Pharmaceuticals

Completed

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Acromegaly

Germany
University of North Carolina, Chapel Hill

Completed

Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
AdventHealth

Terminated

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

Adenoma

United States
University of Southern California
National Cancer Institute (NCI); L K Whittier Foundation

Terminated

Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery

Breast Cancer

United States
Aspireo Pharmaceuticals Limited

Completed

Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173

Healthy
University College, London
University College London Hospitals

Recruiting

TIPS Microspheres for Perianal Fistula

Perianal Fistula

United Kingdom
Brigham and Women's Hospital
Guerbet

Withdrawn

Genicular Artery Embolization (GAE) for the Treatment of Chronic Post Knee Arthroplasty Pain

Arterial Occlusion | Knee Pain Chronic | Knee Swelling Pain

United States
Rhode Island Hospital

Terminated

Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hypertrophy

United States
Tampa General Hospital

Unknown

Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams

Benign Prostatic Hyperplasia

United States
University of Virginia
Siemens Medical Solutions

Unknown

Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Hyperplasia | Male Urogenital Diseases | Prostatic Hypertrophy | Benign Prostatic Hyperplasia (BPH) | Genital Diseases, Male | Lower Urinary Tract Symptoms (LUTS) | Prostatism

United States
South Florida Medical Imaging, PA

Terminated

Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams

Prostatic Hyperplasia

United States
Mayo Clinic

Completed

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Cirrhosis | Portal Hypertension | Esophageal Varices
Siddharth Padia, MD
Boston Scientific Corporation

Completed

Genicular Artery Embolization for the Treatment of Knee Osteoarthritis (GAE-OA)

Knee Osteoarthritis | Degenerative Joint Disease of Knee

United States
Chengfeng Wang

Unknown

The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial

Pancreatic Diseases

China
Novartis Pharmaceuticals

Completed

Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea (LARCID)

Chemotherapy-induced Diarrhea

Brazil
H. Lee Moffitt Cancer Center and Research Institute
BTG International Inc.

Completed

Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma

Cholangiocarcinoma

United States
Peking University

Unknown

Octreotide LAR as Maintenance Treatment for Patients With NEC

Esophageal Neuroendocrine Carcinoma | Gastro-entero-pancreatic Carcinoma

China
University of Miami

Enrolling by invitation

Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate

Benign Prostatic Hyperplasia

United States
University of Virginia
National Institutes of Health (NIH)

Unknown

Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound

Kidney

United States
Emory University

Completed

Low-dose Y90 Treatment Planning for HCC

HCC | Cancer | Cancer of Liver

United States
UMC Utrecht

Terminated

Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors (HIT)

Head and Neck Neoplasms | Radioisotopes

Netherlands
Sidney Kimmel Cancer Center at Thomas Jefferson...

Withdrawn

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery

Renal Cell Carcinoma

United States
UMC Utrecht

Completed

Radioactive Holmium Microspheres for the Treatment of Liver Metastases (HEPAR)

Liver Tumors | Liver Metastasis

Netherlands
Zhongda Hospital

Recruiting

Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma

Unresectable Hepatocellular Carcinoma

China
Radboud University Medical Center
Terumo Medical Corporation; Quirem Medical B.V.

Recruiting

Percutaneous Holmium Injection in Pancreatic Cancer (SLOTH-2a)

Pancreas Cancer

Netherlands
Thomas Jefferson University

Recruiting

Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)

Prostate Carcinoma

United States, Netherlands
University of North Carolina, Chapel Hill

Completed

Geniculate Artery Embolization for the Treatment of Knee Pain (GAE)

Osteoarthritis Of Knee

United States
Boston Scientific Corporation

Terminated

Embozene Microspheres for Uterine Fibroid Embolization (UFE)

Uterine Fibroids

United States
Azidus Brasil

Suspended

Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ®

Acromegaly

Brazil
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting

Transarterial Embolization Alone Versus Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma (RAD-18-TAcE)

Carcinoma, Hepatocellular

Italy
University of North Carolina, Chapel Hill
Terumo Medical Corporation

Terminated

Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia

Prostatic Hyperplasia | BPH | Enlarged Prostate (BPH)

United States

Search clinical trials for: Octreotide microspheres

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations